The Cooper Companies Inc Asset Turnover Ratio (COO), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
The Cooper Companies Inc   (NASDAQ: COO)
 

The Cooper Companies Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

The Cooper Companies Inc asset turnover ratio, the ability of The Cooper Companies Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.34 in the second quarter (Apr 30 2026), yet the ratio remained below the average, as COO's position remain challenging.

Within sector 122 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 2359, from total ranking in the first quarter 2026 at 2360.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COO Asset Turnover Ratio (Apr 30 2026)
II. Quarter		 (Jan 31 2026)
I. Quarter		 (Oct 31 2025)
IV. Quarter		 (Jul 31 2025)
III. Quarter		 (Apr 30 2025)
II. Quarter
Y / Y Asset Change 0.55 % 23.65 % 22.65 % 25.5 % 27.12 %
Y / Y Revenue Change 7.91 % 6.12 % 4.44 % 5.79 % 6.36 %
Asset Turnover Ratio (TTM) 0.34 0.33 0.35 0.36 0.38
COO's Total Ranking # 2359 # 2360 # 2398 # 2318 # 2490
Seq. Asset Change 0.47 % 0.24 % 0.15 % -0.3 % 23.55 %
Seq. Revenue Change 5.69 % -4 % 0.55 % 5.78 % 3.93 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 123
Healthcare Sector # 327
Overall Market # 2359

Asset Turnover Ratio Statistics
High Average Low
6.9 6.25 5.17
(Apr 30 2014)   (Jan 31 2026)




COO Company Profile • Back to COO Efficiency Comparisons • Compare COO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2026 Assets at quarter ending Apr 30 2026
Madrigal Pharmaceuticals Inc   0.93 $ 1,132.490  Millions$ 1,216.189  Millions
Ufp Technologies Inc   0.93 $ 608.621  Millions$ 654.310  Millions
Accuray Incorporated  0.93 $ 427.893  Millions$ 461.224  Millions
Community Health Systems Inc   0.92 $ 12,291.000  Millions$ 13,316.000  Millions
Ironwood Pharmaceuticals inc   0.92 $ 361.514  Millions$ 392.619  Millions
Insulet Corporation  0.92 $ 2,900.800  Millions$ 3,169.025  Millions
Liquidia Corporation  0.91 $ 288.065  Millions$ 315.715  Millions
Apyx Medical Corp  0.90 $ 55.304  Millions$ 61.355  Millions
Cue Biopharma Inc   0.90 $ 32.731  Millions$ 36.360  Millions
Pediatrix Medical Group Inc   0.90 $ 1,931.686  Millions$ 2,154.624  Millions
Verrica Pharmaceuticals Inc   0.90 $ 37.161  Millions$ 41.480  Millions
Genedx Holdings Corp   0.89 $ 442.908  Millions$ 496.944  Millions
Lakeland Industries Inc   0.89 $ 193.318  Millions$ 217.323  Millions
Enhabit Inc   0.89 $ 1,064.900  Millions$ 1,199.925  Millions
Protalix Biotherapeutics inc   0.88 $ 76.381  Millions$ 86.358  Millions
Teladoc Health Inc   0.88 $ 2,514.453  Millions$ 2,859.528  Millions
Alnylam Pharmaceuticals Inc   0.88 $ 4,286.923  Millions$ 4,878.390  Millions
Atara Biotherapeutics Inc   0.88 $ 23.540  Millions$ 26.825  Millions
Eton Pharmaceuticals Inc   0.87 $ 86.614  Millions$ 99.003  Millions
Ardelyx inc   0.87 $ 427.679  Millions$ 489.763  Millions
Si bone inc   0.87 $ 206.128  Millions$ 236.617  Millions
Exelixis Inc   0.87 $ 2,375.491  Millions$ 2,734.911  Millions
Encompass Health Corporation  0.86 $ 6,066.400  Millions$ 7,013.575  Millions
Atricure Inc   0.86 $ 549.625  Millions$ 635.615  Millions
Fennec Pharmaceuticals Inc   0.86 $ 50.999  Millions$ 59.128  Millions
Amneal Pharmaceuticals Inc   0.86 $ 3,045.530  Millions$ 3,560.290  Millions
Xeris Biopharma Holdings Inc   0.85 $ 314.853  Millions$ 370.104  Millions
Adma Biologics Inc   0.84 $ 507.766  Millions$ 604.123  Millions
Bioventus Inc   0.84 $ 575.558  Millions$ 685.620  Millions
Lensar Inc   0.83 $ 57.704  Millions$ 69.568  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.